Cargando…

Ferroptosis becomes immunogenic: implications for anticancer treatments

Ferroptosis is an iron-dependent form of non-apoptotic cell death that has recently been attributed with antitumor immune effects. Thus, early ferroptotic cells underwent immunogenic cell death that was accompanied by the emission of damage-associated molecular patterns (DAMPs) and triggered dendrit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Daolin, Kepp, Oliver, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781761/
https://www.ncbi.nlm.nih.gov/pubmed/33457081
http://dx.doi.org/10.1080/2162402X.2020.1862949
_version_ 1783631742988451840
author Tang, Daolin
Kepp, Oliver
Kroemer, Guido
author_facet Tang, Daolin
Kepp, Oliver
Kroemer, Guido
author_sort Tang, Daolin
collection PubMed
description Ferroptosis is an iron-dependent form of non-apoptotic cell death that has recently been attributed with antitumor immune effects. Thus, early ferroptotic cells underwent immunogenic cell death that was accompanied by the emission of damage-associated molecular patterns (DAMPs) and triggered dendritic cell maturation in vitro. Furthermore, ferroptotic cells were able to vaccinate against a rechallenge with fibrosarcoma in preclinical models.
format Online
Article
Text
id pubmed-7781761
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-77817612021-01-14 Ferroptosis becomes immunogenic: implications for anticancer treatments Tang, Daolin Kepp, Oliver Kroemer, Guido Oncoimmunology Editorial Ferroptosis is an iron-dependent form of non-apoptotic cell death that has recently been attributed with antitumor immune effects. Thus, early ferroptotic cells underwent immunogenic cell death that was accompanied by the emission of damage-associated molecular patterns (DAMPs) and triggered dendritic cell maturation in vitro. Furthermore, ferroptotic cells were able to vaccinate against a rechallenge with fibrosarcoma in preclinical models. Taylor & Francis 2020-12-29 /pmc/articles/PMC7781761/ /pubmed/33457081 http://dx.doi.org/10.1080/2162402X.2020.1862949 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Tang, Daolin
Kepp, Oliver
Kroemer, Guido
Ferroptosis becomes immunogenic: implications for anticancer treatments
title Ferroptosis becomes immunogenic: implications for anticancer treatments
title_full Ferroptosis becomes immunogenic: implications for anticancer treatments
title_fullStr Ferroptosis becomes immunogenic: implications for anticancer treatments
title_full_unstemmed Ferroptosis becomes immunogenic: implications for anticancer treatments
title_short Ferroptosis becomes immunogenic: implications for anticancer treatments
title_sort ferroptosis becomes immunogenic: implications for anticancer treatments
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781761/
https://www.ncbi.nlm.nih.gov/pubmed/33457081
http://dx.doi.org/10.1080/2162402X.2020.1862949
work_keys_str_mv AT tangdaolin ferroptosisbecomesimmunogenicimplicationsforanticancertreatments
AT keppoliver ferroptosisbecomesimmunogenicimplicationsforanticancertreatments
AT kroemerguido ferroptosisbecomesimmunogenicimplicationsforanticancertreatments